Primary Treatment Approach for Chronic Kidney Disease Stage 3A

Blood Pressure Management

The American Heart Association recommends ACE inhibitors or ARBs as first-line therapy for hypertension in CKD stage 3A, especially in patients with albuminuria, with a target blood pressure of <130/80 mmHg 2, 1
The American College of Cardiology recommends a target blood pressure of <130/80 mmHg for most patients with CKD 2, 3
For Black patients with CKD, the American Heart Association suggests initial therapy should include a thiazide-type diuretic or calcium channel blocker, either alone or in combination with a RAS blocker 1
The National Kidney Foundation recommends monitoring serum creatinine and potassium within 2-4 weeks after initiation or dose increase of ACE inhibitors or ARBs 1
The American Journal of Kidney Diseases suggests continuing therapy unless serum creatinine rises by more than 30% within 4 weeks of initiation or dose increase 1, 4

The Kidney International journal recommends avoiding NSAIDs as they can worsen kidney function and interfere with the effectiveness of antihypertensive medications 5

The Kidney International journal recommends treatment with a statin or statin/ezetimibe combination for adults aged ≥50 years with eGFR <60 ml/min per 1.73 m² 5
The Kidney International journal suggests statin treatment for adults aged 18-49 years with CKD who have coronary disease, diabetes mellitus, prior ischemic stroke, or estimated 10-year incidence of coronary death or nonfatal MI >10% 5

The American Diabetes Association recommends SGLT2 inhibitors for patients with diabetic CKD who have eGFR ≥20 mL/min/1.73 m² and type 2 diabetes 6, 1
The American Diabetes Association suggests GLP-1 receptor agonists for cardiovascular risk reduction in patients with diabetic CKD 6, 1
The American Diabetes Association recommends metformin for patients with eGFR ≥45 mL/min/1.73 m² 6

The Kidney International journal recommends low-dose aspirin for secondary prevention in people with CKD and established ischemic cardiovascular disease 5
The Kidney International journal suggests that aspirin is not recommended for primary prevention in CKD patients 3

The American Heart Association recommends advising patients to adopt diets with higher consumption of plant-based foods compared to animal-based foods 1
The National Kidney Foundation suggests maintaining a protein intake of 0.8 g/kg body weight/day 1
The American Journal of Kidney Diseases recommends avoiding high protein intake (>1.3 g/kg/day) in adults with CKD at risk of progression 1
The American Heart Association suggests encouraging moderate-intensity physical activity for at least 150 minutes per week 1
The American Journal of Kidney Diseases recommends sodium restriction (2.3 g/d) to optimize the effectiveness of antihypertensive medications 4

The National Kidney Foundation recommends monitoring for complications of CKD such as hyperkalemia, metabolic acidosis, hyperphosphatemia, vitamin D deficiency, secondary hyperparathyroidism, and anemia 1
The American Journal of Kidney Diseases suggests regular risk factor reassessment every 3-6 months 1
The Diabetes Care journal recommends monitoring blood pressure, weight, serum electrolytes, hemoglobin, calcium, phosphate, PTH, and vitamin D levels 6

The American Heart Association recommends avoiding simultaneous use of ACE inhibitors and ARBs as this combination increases risk of hyperkalemia and acute kidney injury without providing additional benefits 2, 4
The American Journal of Kidney Diseases suggests monitoring for orthostatic hypotension when initiating or increasing doses of antihypertensive medications 7
The American Heart Association recommends recognizing that blood pressure targets may need to be individualized in elderly or frail patients to avoid adverse events 2